Latest Period
Q2 2026
Security Snapshot
Neurogene Inc. - Common Stock, $0.000001 par value per share (NGNE) Institutional Ownership
CUSIP: 64135M105
13F Institutional Holders and Ownership History from Q4 2023 to Q2 2026
Institutions Reporting
112
Shares (Excl. Options)
17,312,171
Price
$31.45
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.000001 par value per share
- Symbol
- NGNE on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 17,312,171
- Total 13F value
- $544,437,963
- Portfolio coverage rank
- 0%
- Share change
- +344,483
- Value change
- +$11,090,129
- Number of holders
- 112
- Shares outstanding
- 15,886,333
- SEC-reported price per share
- $32.89
- Insider filing price
- $32.89
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- NGNE - Neurogene Inc. - Common Stock, $0.000001 par value per share is tracked under CUSIP 64135M105.
- 112 institutions reported positions in Q2 2026.
- 11 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 95 to 112 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $341,973,223 to $544,437,963.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 112 institutions filings for Q2 2026.
Security key
64135M105
Latest holder period
Q2 2026
13F holders
112
13D/G owners
11
CIK / CUSIP context first
Open Q2 2026 holders
NGNE full holder history
Neurogene Inc. SEC filings
Neurogene Inc. company facts
Neurogene Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 64135M105:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
11
Security
NGNE
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Redmile Group, LLC | 9.9% | 0% | $60,121,004 | +$574,480 | 1,572,202 | +0.96% | Redmile Group, LLC | 30 Jun 2026 |
| RTW INVESTMENTS, LP | 10% | $23,096,955 | 1,498,829 | RTW Investments, LP | 31 Dec 2024 | |||
| EcoR1 Capital, LLC | 9.9% | $25,005,492 | 1,442,902 | EcoR1 Capital, LLC | 30 Sep 2025 | |||
| Casdin Capital, LLC | 8.7% | $19,961,513 | 1,295,361 | Casdin Capital, LLC | 31 Dec 2024 | |||
| BlackRock, Inc. | 6.8% | $15,586,229 | 1,011,436 | BlackRock, Inc. | 31 Mar 2025 | |||
| BAKER BROS. ADVISORS LP | 7% | -30% | $21,254,360 | -$10,597,328 | 991,804 | -33% | Julian C. Baker | 30 Jun 2025 |
| BALYASNY ASSET MANAGEMENT L.P. | 5.2% | $31,307,317 | 818,706 | BALYASNY ASSET MANAGEMENT L.P. | 30 Jun 2026 | |||
| Trails Edge Capital Partners, LP | 4.5% | -12% | $27,337,202 | -$2,681,198 | 714,885 | -8.9% | Trails Edge Capital Partners, LP | 30 Jun 2026 |
| FMR LLC | 3.1% | $7,132,965 | 462,879 | FMR LLC | 31 Mar 2025 | |||
| GREAT POINT PARTNERS LLC | 3% | $6,822,947 | 442,761 | Great Point Partners, LLC | 31 Dec 2024 | |||
| Commodore Capital LP | 3% | $9,169,168 | 427,866 | Commodore Capital LP | 30 Jun 2025 |
As of 30 Jun 2026, 112 institutional investors reported holding 17,312,171 shares of Neurogene Inc. - Common Stock, $0.000001 par value per share (NGNE). This represents 109% of the company’s total 15,886,333 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
99%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | 11% | 1,717,127 | 0% | 4.4% | $54,003,644 |
| Casdin Capital, LLC | 9.7% | 1,545,361 | +8.8% | 2.4% | $48,601,603 |
| Redmile Group, LLC | 8.9% | 1,412,199 | -3.2% | 3% | $44,413,659 |
| RTW INVESTMENTS, LP | 8.6% | 1,362,456 | 0% | 0.37% | $42,849,241 |
| EcoR1 Capital, LLC | 8% | 1,271,342 | 0% | 2% | $39,983,706 |
| BlackRock, Inc. | 6.7% | 1,057,983 | +5.3% | 0% | $33,273,565 |
| BAKER BROS. ADVISORS LP | 6.2% | 991,691 | 0% | 0.16% | $31,188,682 |
| Balyasny Asset Management L.P. | 5.2% | 818,706 | +14% | 0.05% | $25,748,307 |
| Trails Edge Capital Partners, LP | 4.5% | 714,885 | -8.7% | 3.6% | $22,483,133 |
| TORONTO DOMINION BANK | 4.3% | 681,337 | 0% | 0.04% | $21,428,049 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.4% | 536,525 | +4.2% | 0% | $16,873,711 |
| JENNISON ASSOCIATES LLC | 3.3% | 518,582 | -1.7% | 0.01% | $16,309,405 |
| CITADEL ADVISORS LLC | 2.6% | 408,982 | +5.7% | 0.01% | $12,862,484 |
| GREAT POINT PARTNERS LLC | 2.2% | 352,180 | -30% | 2.6% | $11,076,061 |
| ArrowMark Colorado Holdings LLC | 2.2% | 342,453 | -35% | 0.45% | $10,770,147 |
| FMR LLC | 1.9% | 295,561 | -23% | 0% | $9,295,393 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 293,182 | +5.1% | 0% | $9,222,612 |
| STATE STREET CORP | 1.4% | 224,322 | -28% | 0% | $7,054,927 |
| FRANKLIN RESOURCES INC | 1.3% | 204,280 | 0% | $6,424,606 | |
| MORGAN STANLEY | 1.2% | 191,724 | -33% | 0% | $6,029,719 |
| UBS Group AG | 1.1% | 171,289 | -7.7% | 0% | $5,387,039 |
| BLAIR WILLIAM & CO/IL | 0.92% | 146,905 | -13% | 0.01% | $4,620,162 |
| Driehaus Capital Management LLC | 0.9% | 143,528 | +338% | 0.03% | $4,513,956 |
| Point72 Asset Management, L.P. | 0.89% | 141,920 | 0.01% | $4,463,384 | |
| MOORE CAPITAL MANAGEMENT, LP | 0.89% | 141,636 | 0.1% | $4,454,452 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
11
Latest
Q2 2026
Rows shown
1-11 of 11
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 17,312,171 | $544,437,963 | +$11,090,129 | $31.45 | 112 |
| 2026 Q1 | 16,969,501 | $341,973,223 | +$9,133,403 | $20.16 | 95 |
| 2025 Q4 | 16,492,025 | $339,874,510 | +$9,470,657 | $20.60 | 92 |
| 2025 Q3 | 15,299,947 | $265,173,378 | -$165,308 | $17.33 | 88 |
| 2025 Q2 | 15,388,370 | $230,113,281 | -$13,642,147 | $14.95 | 81 |
| 2025 Q1 | 16,456,922 | $192,796,009 | +$733,702 | $11.71 | 83 |
| 2024 Q4 | 16,089,357 | $367,798,856 | +$14,465,324 | $22.86 | 86 |
| 2024 Q3 | 13,847,659 | $581,113,931 | +$18,023,436 | $41.96 | 85 |
| 2024 Q2 | 13,265,527 | $482,740,723 | +$37,443,874 | $36.39 | 66 |
| 2024 Q1 | 12,128,797 | $617,303,585 | +$152,848,957 | $50.90 | 58 |
| 2023 Q4 | 9,233,865 | $178,953,482 | +$178,848,733 | $19.38 | 35 |